Pain Management Certificate Program

JULY 28TH | VIRTUAL WEBINAR

An innovative and comprehensive learning activity developed to assist pharmacists to maintain and enhance their professional competencies in pain management.

Fall Conference

SEPTEMBER 15TH | SCOTTSDALE, AZ

SAVE THE DATE | This one-day conference provides continuing education and networking opportunities for pharmacy professionals looking to be updated on pharmacy related hot topics.

REGISTRATION COMING SOON

AzPA Immunization Certificate Program

SEPTEMBER 8TH | TUCSON, AZ
SEPTEMBER 29-30TH | GLENDALE, AZ

This program is an interactive educational program that provides pharmacists and student pharmacists with the skills necessary to become primary sources for vaccine advocacy, education, and administration.

APhA Cardiovascular Disease Risk Management

AUGUST 4TH | ALBUQUERQUE, NM

An innovative and interactive certificate training program that explores the pharmacist’s role in cardiovascular disease risk management. This practice-based activity is the first step for pharmacists interested in learning the essential skills to successfully assess risk, promote cardiovascular disease prevention, and encourage patient adherence to therapy.

Educate

Learn with us

Advocate

Discover your voice

Connect

Get involved! Serve on a team

RSS AzPA Pharmacy Flash

  • Why Amazon's push into prescription drugs isn't a guaranteed success
    When Amazon announced last week that it was buying the online pharmacy PillPack, it sent stocks of drugstore companies like Walgreens and Rite Aid tumbling, as investors worried that the retail behemoth would soon upend the pharmacy market. But even though Amazon has transformed the way Americans buy products as different as books and diapers, […]
  • Pharmacists can help manage drug costs if state and federal laws just let them
    For decades, our government has attempted to address one of the most pressing healthcare problems in our country — skyrocketing drug prices — to little avail. Recently, Secretary of Health and Human Services Alex Azar testified before the Senate Finance Committee addressing the challenges of prescription drug affordability for millions of Americans.
  • Schizophrenia regimen approved by FDA
    Officials with the FDA have approved an Alkermes aripiprazole lauroxil (Aristada Initio) extended-release product for the treatment of schizophrenia in adults, according to the company. Aristada Initio leverages proprietary NanoCrystal technology, and the drug utilizes a smaller particle size than Alkermes’ Aristada, an injectable atypical antipsychotic medication that also contains aripiprazole lauroxil.

Upcoming Events

Upcoming Events

AzPA IMZ Certificate Training Program

09/08/2018 - 09/08/2018

University of Arizona

AzPA IMZ Certificate Training Program

09/29/2018 - 09/30/2018

Midwestern University